Atlas Trials

Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy

Clinical trial NCT02097823 · COMPLETED

Trial details

NCT number
NCT02097823
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy Induced Nausea and Vomiting
Start date
2014-02-01
Primary completion
2015-02-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.